United States
AIM at Melanoma
Founded in 2004, AIM at Melanoma is a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma.
Disease-specific groupUnited States
A Cure in Sight is a patient group in the United States, focused on ocular melanoma.
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it.
This page is made by Triangle.
What they do
World's largest resource for ocular and uveal melanoma information. Find expert insights, support, and the latest research.
Based in the United States. Focus: ocular melanoma. Listed by NORD Rare Cancer Coalition. US tax-exempt organisation. Latest IRS filing: $650,861.
The opening description is taken from the organisation’s own website. The rest is compiled from coalition directories and charity registers.
On the record
For you, or someone you love
Triangle brings your medical records, genetic results and wearables into one place that you control, with your records organised by condition. Ask about your own file in plain language, and walk into every appointment knowing what to ask.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks, next to your genetic results and wearables. Add scans and anything on paper.
Reports explained as they come in, organised by condition, with lab values you can follow over time.
Ask about your own file, and walk in knowing what to ask your doctors.
Share one profile with the family helping you, and with your doctors.